Rosalind Ramsey-Goldman, MD, DrPH earned her bachelor's and medical degrees from Case Western Reserve University in Cleveland, Ohio, in 1975 and 1978, respectively. She completed her residency at the University of Rochester in 1981, fellowship in rheumatology and clinical immunology at the University of Pittsburgh in 1986, and earned her doctorate in public health from the University of Pittsburgh Graduate School in Public Health in 1992. In 1991, Dr. Ramsey-Goldman joined Northwestern University as an assistant professor of medicine. Dr. Ramsey-Goldman was appointed associate professor of medicine in 1996 and professor of medicine in 2001. Dr. Ramsey-Goldman was appointed Solovy/Arthritis Research Society Research Professor in 2007. She currently serves as associate director for clinical research for the training grant in rheumatology, and program director for the clinic research unit within the Center for Clinical Research in the Northwestern University Clinical and Translational Sciences (NUCATS) Institute.
Dr. Ramsey-Goldman is the primary investigator for the Patient-Oriented Clinical Research Program in Systemic Lupus Erythematosis (SLE), funded by NIH grants and foundation support, investigating SLE prevention and complications. Dr. Ramsey-Goldman presented the Thomas Lecture at Virginia Commonwealth University and was named Pfizer Visiting Professor at Medical University of South Carolina in April 2008 and March 2009, respectively. She is recent past chair of the Systemic Lupus Collaborating Clinics group. She also serves on the editorial board of Arthritis and Rheumatism.
Dr. Ramsey-Goldman's interests lie primarily in the clinical treatment of and research in understanding the natural history of systemic lupus erythematosus (SLE). Her specific interests include the effects of lupus on pregnancy, the correlation between bone disease and immunosuppression, the epidemiology of SLE, genetics and SLE vascular disease and SLE, and a range of clinical trials related to the treatment of lupus and its debilitating symptoms. Dr. Ramsey-Goldman's goal is to improve the quality of life for lupus patients through her epidemiological, pregnancy, and drug studies. She is currently involved in investigating the epidemiology of osteoporosis in women with lupus, new drugs to treat lupus nephritis, steroid-induced osteoporosis, genetics and SLE vascular disease and SLE, and cancer risk and SLE.
Major Research Interests:
Rheumatic diseases and pregnancy
Lupus and pregnancy
Epidemiology of Systemic Lupus Erythematosus
Genetics and Systemic Lupus Erythematosus
Bone disease and immunosuppression
Cardiovascular Disease and SLE
SLE clinical trials